Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System

Cell Metabolism

Volumn 26, Issue 1, 2017, Pages 110-130

  Postler, Thomas Siegmund ^a   Ghosh, Sankar ^a  

^a Columbia University ^*  (United States)

Author keywords

atherosclerosis; commensals; indole; inflammatory bowel disease; metabolic syndrome; microbiome; obesity; polyamine; polysaccharide A; short chain fatty acids

Indexed keywords

BILE ACID; POLYAMINE;

ATHEROSCLEROSIS; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INTESTINE FLORA; METABOLIC DISORDER; METABOLITE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; ANIMAL; BACTERIUM; INFLAMMATORY BOWEL DISEASE; METABOLISM; METABOLOME; MICROBIOLOGY;

ANIMALS; BACTERIA; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; METABOLIC DISEASES; METABOLOME;

EID: 85020788732     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2017.05.008     Document Type: Review

References (257)

1. Adair, K.L., Douglas, A.E., Making a microbiome: the many determinants of host-associated microbial community composition. Curr. Opin. Microbiol. 35 (2016), 23–29.
2. Alex, S., Lange, K., Amolo, T., Grinstead, J.S., Haakonsson, A.K., Szalowska, E., Koppen, A., Mudde, K., Haenen, D., Al-Lahham, S., et al. Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ. Mol. Cell. Biol. 33 (2013), 1303–1316.
3. Allard, B., Longhi, M.S., Robson, S.C., Stagg, J., The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol. Rev. 276 (2017), 121–144.
4. Are, A., Aronsson, L., Wang, S., Greicius, G., Lee, Y.K., Gustafsson, J.-A., Pettersson, S., Arulampalam, V., Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells. Proc. Natl. Acad. Sci. USA 105 (2008), 1943–1948.
5. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J.R., Pfeffer, K., Coffer, P.J., Rudensky, A.Y., Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504 (2013), 451–455.
6. Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H., Ishii, N., Evans, R., Honda, K., Takeda, K., ATP drives lamina propria T(H)17 cell differentiation. Nature 455 (2008), 808–812.
7. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500 (2013), 232–236.
8. Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S., Suda, W., Imaoka, A., Setoyama, H., Nagamori, T., et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163 (2015), 367–380.
9. Bested, A.C., Logan, A.C., Selhub, E.M., Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part I—autointoxication revisited. Gut Pathog., 5, 2013, 5.
10. Bianconi, E., Piovesan, A., Facchin, F., Beraudi, A., Casadei, R., Frabetti, F., Vitale, L., Pelleri, M.C., Tassani, S., Piva, F., et al. An estimation of the number of cells in the human body. Ann. Hum. Biol. 40 (2013), 463–471.
11. Blekhman, R., Goodrich, J.K., Huang, K., Sun, Q., Bukowski, R., Bell, J.T., Spector, T.D., Keinan, A., Ley, R.E., Gevers, D., Clark, A.G., Host genetic variation impacts microbiome composition across human body sites. Genome Biol., 16, 2015, 191.
12. Bloemen, J.G., Venema, K., van de Poll, M.C., Olde Damink, S.W., Buurman, W.A., Dejong, C.H., Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clin. Nutr. 28 (2009), 657–661.
13. Boutagy, N.E., McMillan, R.P., Frisard, M.I., Hulver, M.W., Metabolic endotoxemia with obesity: Is it real and is it relevant?. Biochimie 124 (2016), 11–20.
14. Brestoff, J.R., Artis, D., Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 14 (2013), 676–684.
15. Breuer, R.I., Buto, S.K., Christ, M.L., Bean, J., Vernia, P., Paoluzi, P., Di Paolo, M.C., Caprilli, R., Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig. Dis. Sci. 36 (1991), 185–187.
16. Brophy, M.L., Dong, Y., Wu, H., Rahman, H.N.A., Song, K., Chen, H., Eating the dead to keep atherosclerosis at bay. Front. Cardiovasc. Med., 4, 2017, 2.
17. Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D., Muir, A.I., Wigglesworth, M.J., Kinghorn, I., Fraser, N.J., et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278 (2003), 11312–11319.
18. Buts, J.P., De Keyser, N., Kolanowski, J., Sokal, E., Van Hoof, F., Maturation of villus and crypt cell functions in rat small intestine. Role of dietary polyamines. Dig. Dis. Sci. 38 (1993), 1091–1098.
19. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
20. Cannon, P.R., The effects of diet on the intestinal flora. J. Infect. Dis. 29 (1921), 369–385.
21. Chang, P.V., Hao, L., Offermanns, S., Medzhitov, R., The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. USA 111 (2014), 2247–2252.
22. Chen, J., Rao, J.N., Zou, T., Liu, L., Marasa, B.S., Xiao, L., Zeng, X., Turner, D.J., Wang, J.-Y., Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 293 (2007), G568–G576.
23. Cipriani, S., Mencarelli, A., Chini, M.G., Distrutti, E., Renga, B., Bifulco, G., Baldelli, F., Donini, A., Fiorucci, S., The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One, 6, 2011, e25637.
24. Clausen, M.R., Mortensen, P.B., Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut 37 (1995), 684–689.
25. Cobb, B.A., Wang, Q., Tzianabos, A.O., Kasper, D.L., Polysaccharide processing and presentation by the MHCII pathway. Cell 117 (2004), 677–687.
26. Collins, H.L., Drazul-Schrader, D., Sulpizio, A.C., Koster, P.D., Williamson, Y., Adelman, S.J., Owen, K., Sanli, T., Bellamine, A., L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(−/−) transgenic mice expressing CETP. Atherosclerosis 244 (2016), 29–37.
27. Cotillard, A., Kennedy, S.P., Kong, L.C., Prifti, E., Pons, N., Le Chatelier, E., Almeida, M., Quinquis, B., Levenez, F., Galleron, N., et al., ANR MicroObes Consortium. Dietary intervention impact on gut microbial gene richness. Nature 500 (2013), 585–588.
28. Cox, L.M., Blaser, M.J., Pathways in microbe-induced obesity. Cell Metab. 17 (2013), 883–894.
29. Creely, S.J., McTernan, P.G., Kusminski, C.M., Fisher, M., Da Silva, N.F., Khanolkar, M., Evans, M., Harte, A.L., Kumar, S., Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292 (2007), E740–E747.
30. Croasdell, A., Duffney, P.F., Kim, N., Lacy, S.H., Sime, P.J., Phipps, R.P., PPARγ and the innate immune system mediate the resolution of inflammation. PPAR Res., 2015, 2015, 549691.
31. Cummings, J.H., Macfarlane, G.T., Role of intestinal bacteria in nutrient metabolism. JPEN J. Parenter. Enteral Nutr. 21 (1997), 357–365.
32. Cummings, J.H., Pomare, E.W., Branch, W.J., Naylor, C.P., Macfarlane, G.T., Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28 (1987), 1221–1227.
33. Dasgupta, S., Erturk-Hasdemir, D., Ochoa-Reparaz, J., Reinecker, H.-C., Kasper, D.L., Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe 15 (2014), 413–423.
34. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
35. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., Collini, S., Pieraccini, G., Lionetti, P., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 107 (2010), 14691–14696.
36. DiNicolantonio, J.J., Lavie, C.J., Fares, H., Menezes, A.R., O'Keefe, J.H., L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin. Proc. 88 (2013), 544–551.
37. Donath, M.Y., Dalmas, É., Sauter, N.S., Böni-Schnetzler, M., Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab. 17 (2013), 860–872.
38. Donohoe, D.R., Collins, L.B., Wali, A., Bigler, R., Sun, W., Bultman, S.J., The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48 (2012), 612–626.
39. Dou, W., Zhang, J., Zhang, E., Sun, A., Ding, L., Chou, G., Wang, Z., Mani, S., Chrysin ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-κB signaling pathway. J. Pharmacol. Exp. Ther. 345 (2013), 473–482.
40. Duboc, H., Rajca, S., Rainteau, D., Benarous, D., Maubert, M.-A., Quervain, E., Thomas, G., Barbu, V., Humbert, L., Despras, G., et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62 (2013), 531–539.
41. Dufour, C., Dandrifosse, G., Forget, P., Vermesse, F., Romain, N., Lepoint, P., Spermine and spermidine induce intestinal maturation in the rat. Gastroenterology 95 (1988), 112–116.
42. Duncan, S.H., Holtrop, G., Lobley, G.E., Calder, A.G., Stewart, C.S., Flint, H.J., Contribution of acetate to butyrate formation by human faecal bacteria. Br. J. Nutr. 91 (2004), 915–923.
43. Duncan, S.H., Louis, P., Flint, H.J., Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70 (2004), 5810–5817.
44. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
45. El Kaoutari, A., Armougom, F., Gordon, J.I., Raoult, D., Henrissat, B., The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Micro. 11 (2013), 497–504.
46. Erny, D., Hrabě de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18 (2015), 965–977.
47. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110 (2013), 9066–9071.
48. Faas, M.M., Sáez, T., de Vos, P., Extracellular ATP and adenosine: the Yin and Yang in immune responses?. Mol. Aspects Med., 2017, 10.1016/j.mam.2017.01.002 S0098-2997(16)30082-6.
49. Fändriks, L., Roles of the gut in the metabolic syndrome: an overview. J. Intern. Med. 281 (2017), 319–336.
50. Ferreira, C.M., Vieira, A.T., Vinolo, M.A.R., Oliveira, F.A., Curi, R., Martins, Fdos.S., The central role of the gut microbiota in chronic inflammatory diseases. J. Immunol. Res., 2014, 2014, 689492.
51. Fleischer, J., Bumbalo, R., Bautze, V., Strotmann, J., Breer, H., Expression of odorant receptor Olfr78 in enteroendocrine cells of the colon. Cell Tissue Res. 361 (2015), 697–710.
52. Flint, H.J., Duncan, S.H., Scott, K.P., and Louis, P. 2015. Links between diet, gut microbiota composition and gut metabolism. Presented at the The Proceedings of the Nutrition Society, pp. 13–22.
53. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104 (2007), 13780–13785.
54. Friedman, D.J., Künzli, B.M., A-Rahim, Y.I., Sevigny, J., Berberat, P.O., Enjyoji, K., Csizmadia, E., Friess, H., Robson, S.C., CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Nat. Acad. Sci. 106 (2009), 16788–16793.
55. Frostegård, J., Immunity, atherosclerosis and cardiovascular disease. BMC Med., 11, 2013, 117.
56. Fu, S., Zhang, N., Yopp, A.C., Chen, D., Mao, M., Chen, D., Zhang, H., Ding, Y., Bromberg, J.S., TGF-beta induces Foxp3+ T-regulatory cells from CD4+ CD25− precursors. Am. J. Transplant. 4 (2004), 1614–1627.
57. Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J.M., Topping, D.L., Suzuki, T., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469 (2011), 543–547.
58. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
59. Gadaleta, R.M., van Erpecum, K.J., Oldenburg, B., Willemsen, E.C.L., Renooij, W., Murzilli, S., Klomp, L.W.J., Siersema, P.D., Schipper, M.E.I., Danese, S., et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60 (2011), 463–472.
60. Garg, A., Zhao, A., Erickson, S.L., Mukherjee, S., Lau, A.J., Alston, L., Chang, T.K.H., Mani, S., Hirota, S.A., Pregnane X receptor activation attenuates inflammation-associated intestinal epithelial barrier dysfunction by inhibiting cytokine-induced myosin light-chain kinase expression and c-Jun N-terminal kinase 1/2 activation. J. Pharmacol. Exp. Ther. 359 (2016), 91–101.
61. Gaudier, E., Jarry, A., Blottière, H.M., de Coppet, P., Buisine, M.P., Aubert, J.P., Laboisse, C., Cherbut, C., Hoebler, C., Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004), G1168–G1174.
62. Geva-Zatorsky, N., Sefik, E., Kua, L., Pasman, L., Tan, T.G., Ortiz-Lopez, A., Yanortsang, T.B., Yang, L., Jupp, R., Mathis, D., et al. Mining the human gut microbiota for immunomodulatory organisms. Cell 168 (2017), 928–943.
63. Ghoshal, S., Witta, J., Zhong, J., de Villiers, W., Eckhardt, E., Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 50 (2009), 90–97.
64. Gibson, D.J., Elliott, L., McDermott, E., Tosetto, M., Keegan, D., Byrne, K., Martin, S.T., Rispens, T., Cullen, G., Mulcahy, H.E., et al. Heightened expression of CD39 by regulatory T lymphocytes is associated with therapeutic remission in inflammatory bowel disease. Inflamm. Bowel Dis. 21 (2015), 2806–2814.
65. Goto, Y., Panea, C., Nakato, G., Cebula, A., Lee, C., Diez, M.G., Laufer, T.M., Ignatowicz, L., Ivanov, I.I., Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 40 (2014), 594–607.
66. Gregory, J.C., Buffa, J.A., Org, E., Wang, Z., Levison, B.S., Zhu, W., Wagner, M.A., Bennett, B.J., Li, L., DiDonato, J.A., et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J. Biol. Chem. 290 (2015), 5647–5660.
67. Guo, X., Rao, J.N., Liu, L., Zou, T.-T., Turner, D.J., Bass, B.L., Wang, J.-Y., Regulation of adherens junctions and epithelial paracellular permeability: a novel function for polyamines. Am. J. Physiol. Cell Physiol. 285 (2003), C1174–C1187.
68. Guo, X., Rao, J.N., Liu, L., Zou, T., Keledjian, K.M., Boneva, D., Marasa, B.S., Wang, J.-Y., Polyamines are necessary for synthesis and stability of occludin protein in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005), G1159–G1169.
69. Guo, C., Qi, H., Yu, Y., Zhang, Q., Su, J., Yu, D., Huang, W., Chen, W.-D., Wang, Y.-D., The G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits gastric inflammation through antagonizing NF-κB signaling pathway. Front. Pharmacol., 6, 2015, 287.
70. Harig, J.M., Soergel, K.H., Komorowski, R.A., Wood, C.M., Treatment of diversion colitis with short-chain-fatty acid irrigation. N. Engl. J. Med. 320 (1989), 23–28.
71. Herter, C.A., Kendall, A.I., The influence of dietary alterations on the types of intestinal flora. J. Biol. Chem. 7 (1910), 203–239.
72. Hironaka, I., Iwase, T., Sugimoto, S., Okuda, K., Tajima, A., Yanaga, K., Mizunoe, Y., Glucose triggers ATP secretion from bacteria in a growth-phase-dependent manner. Appl. Environ. Microbiol. 79 (2013), 2328–2335.
73. Hirschler, A., Ueber den Einfluss der Kohlehydrate und einiger anderer Körper der Fettsäurereihe auf die Eiweissfäulniss. Zeitschrift für Physiologische Chemie 10 (1886), 306–317.
74. Hold, G.L., Pryde, S.E., Russell, V.J., Furrie, E., Flint, H.J., Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol. Ecol. 39 (2002), 33–39.
75. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
76. Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139 (2009), 485–498.
77. Iwase, T., Shinji, H., Tajima, A., Sato, F., Tamura, T., Iwamoto, T., Yoneda, M., Mizunoe, Y., Isolation and identification of ATP-secreting bacteria from mice and humans. J. Clin. Microbiol. 48 (2010), 1949–1951.
78. Jiang, F., Meng, D., Weng, M., Zhu, W., Wu, W., Kasper, D., Walker, W.A., The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1β-induced inflammation in human fetal enterocytes via toll receptors 2 and 4. PLoS One, 12, 2017, e0172738.
79. Johnson, J.L., Jones, M.B., Cobb, B.A., Polysaccharide A from the capsule of Bacteroides fragilis induces clonal CD4+ T cell expansion. J. Biol. Chem. 290 (2015), 5007–5014.
80. Jonsson, A.L., Bäckhed, F., Role of gut microbiota in atherosclerosis. Nat. Rev. Cardiol. 14 (2017), 79–87.
81. Kalina, U., Koyama, N., Hosoda, T., Nuernberger, H., Sato, K., Hoelzer, D., Herweck, F., Manigold, T., Singer, M.V., Rossol, S., Böcker, U., Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region. Eur. J. Immunol. 32 (2002), 2635–2643.
82. Kanauchi, O., Suga, T., Tochihara, M., Hibi, T., Naganuma, M., Homma, T., Asakura, H., Nakano, H., Takahama, K., Fujiyama, Y., et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J. Gastroenterol. 37:Suppl 14 (2002), 67–72.
83. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B., Nielsen, J., Bäckhed, F., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103.
84. Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278 (2003), 9435–9440.
85. Keitel, V., Donner, M., Winandy, S., Kubitz, R., Häussinger, D., Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem. Biophys. Res. Commun. 372 (2008), 78–84.
86. Kelly, D., Campbell, J.I., King, T.P., Grant, G., Jansson, E.A., Coutts, A.G.P., Pettersson, S., Conway, S., Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 5 (2004), 104–112.
87. Khan, M.T., Nieuwdorp, M., Bäckhed, F., Microbial modulation of insulin sensitivity. Cell Metab. 20 (2014), 753–760.
88. Kim, I., Morimura, K., Shah, Y., Yang, Q., Ward, J.M., Gonzalez, F.J., Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28 (2007), 940–946.
89. Kim, M., Qie, Y., Park, J., Kim, C.H., Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 20 (2016), 202–214.
90. Kiss, E.A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., Diefenbach, A., Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334 (2011), 1561–1565.
91. Koeth, R.A., Wang, Z., Levison, B.S., Buffa, J.A., Org, E., Sheehy, B.T., Britt, E.B., Fu, X., Wu, Y., Li, L., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19 (2013), 576–585.
92. Koeth, R.A., Levison, B.S., Culley, M.K., Buffa, J.A., Wang, Z., Gregory, J.C., Org, E., Wu, Y., Li, L., Smith, J.D., et al. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 20 (2014), 799–812.
93. Koh, A., De Vadder, F., Kovatcheva-Datchary, P., Bäckhed, F., From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165 (2016), 1332–1345.
94. Kudoh, K., Shimizu, J., Wada, M., Takita, T., Kanke, Y., Innami, S., Effect of indigestible saccharides on B lymphocyte response of intestinal mucosa and cecal fermentation in rats. J. Nutr. Sci. Vitaminol. (Tokyo) 44 (1998), 103–112.
95. Kurokawa, K., Itoh, T., Kuwahara, T., Oshima, K., Toh, H., Toyoda, A., Takami, H., Morita, H., Sharma, V.K., Srivastava, T.P., et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14 (2007), 169–181.
96. Kusu, T., Kayama, H., Kinoshita, M., Jeon, S.G., Ueda, Y., Goto, Y., Okumura, R., Saiga, H., Kurakawa, T., Ikeda, K., et al. Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine. J. Immunol. 190 (2013), 774–783.
97. Lam, D.W., LeRoith, D., Metabolic syndrome. De Groot, L.J., Chrousos, G., Dungan, K., Feingold, K.R., Grossman, A., Hershman, J.M., Koch, C., Korbonits, M., McLachlan, R., New, M., et al. (eds.) Endotext, 2015, MDText.com, Inc.
98. Lamas, B., Richard, M.L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T.W., Natividad, J.M., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22 (2016), 598–605.
99. Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278 (2003), 25481–25489.
100. Lee, J.S., Cella, M., McDonald, K.G., Garlanda, C., Kennedy, G.D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C.A., Newberry, R.D., Colonna, M., AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13 (2011), 144–151.
101. Lenz, K., Jensen, K.B., Jarnum, S., Bile acid metabolism and plasma protein turnover in Crohn's disease. Scand. J. Gastroenterol. 11 (1976), 721–727.
102. Levy, M., Thaiss, C.A., Zeevi, D., Dohnalová L., Zilberman-Schapira, G., Mahdi, J.A., David, E., Savidor, A., Korem, T., Herzig, Y., et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163 (2015), 1428–1443.
103. Levy, M., Thaiss, C.A., Elinav, E., Metabolites: messengers between the microbiota and the immune system. Genes Dev. 30 (2016), 1589–1597.
104. Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102 (2005), 11070–11075.
105. Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006), 1022–1023.
106. Li, Y., Innocentin, S., Withers, D.R., Roberts, N.A., Gallagher, A.R., Grigorieva, E.F., Wilhelm, C., Veldhoen, M., Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147 (2011), 629–640.
107. Li, S.S., Zhu, A., Benes, V., Costea, P.I., Hercog, R., Hildebrand, F., Huerta-Cepas, J., Nieuwdorp, M., Salojärvi, J., Voigt, A.Y., et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352 (2016), 586–589.
108. Li, X.S., Obeid, S., Klingenberg, R., Gencer, B., Mach, F., Räber, L., Windecker, S., Rodondi, N., Nanchen, D., Muller, O., et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur. Heart J. 38 (2017), 814–824.
109. Liu, L., Guo, X., Rao, J.N., Zou, T., Xiao, L., Yu, T., Timmons, J.A., Turner, D.J., Wang, J.Y., Polyamines regulate E-cadherin transcription through c-Myc modulating intestinal epithelial barrier function. Am. J. Physiol. Cell Physiol. 296 (2009), C801–C810.
110. Liu, L., Li, L., Min, J., Wang, J., Wu, H., Zeng, Y., Chen, S., Chu, Z., Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cell. Immunol. 277 (2012), 66–73.
111. Löser, C., Eisel, A., Harms, D., Fölsch, U.R., Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development. Gut 44 (1999), 12–16.
112. Louis, P., Young, P., Holtrop, G., Flint, H.J., Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ. Microbiol. 12 (2010), 304–314.
113. Lührs, H., Gerke, T., Müller, J.G., Melcher, R., Schauber, J., Boxberge, F., Scheppach, W., Menzel, T., Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand. J. Gastroenterol. 37 (2002), 458–466.
114. Lux, G.D., Marton, L.J., Baylin, S.B., Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats. Science 210 (1980), 195–198.
115. Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63 (2014), 1275–1283.
116. Macia, L., Tan, J., Vieira, A.T., Leach, K., Stanley, D., Luong, S., Maruya, M., Ian McKenzie, C., Hijikata, A., Wong, C., et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun., 6, 2015, 6734.
117. Maehre, H.K., Jensen, I.-J., Elvevoll, E.O., Eilertsen, K.-E., ω-3 fatty acids and cardiovascular diseases: effects, mechanisms and dietary relevance. Int. J. Mol. Sci. 16 (2015), 22636–22661.
118. Makishima, M., Okamoto, A.Y., Repa, J.J., Tu, H., Learned, R.M., Luk, A., Hull, M.V., Lustig, K.D., Mangelsdorf, D.J., Shan, B., Identification of a nuclear receptor for bile acids. Science 284 (1999), 1362–1365.
119. Manor, O., Borenstein, E., Systematic characterization and analysis of the taxonomic drivers of functional shifts in the human microbiome. Cell Host Microbe 21 (2017), 254–267.
120. Mardinoglu, A., Shoaie, S., Bergentall, M., Ghaffari, P., Zhang, C., Larsson, E., Bäckhed, F., Nielsen, J., The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol. Syst. Biol., 11, 2015, 834.
121. Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M., Dixit, V.M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006), 228–232.
122. Marotz, C.A., Zarrinpar, A., Treating obesity and metabolic syndrome with fecal microbiota transplantation. Yale J. Biol. Med. 89 (2016), 383–388.
123. Marques, C.C., Castelo-Branco, M.T., Pacheco, R.G., Buongusto, F., do Rosário, A. Jr., Schanaider, A., Coutinho-Silva, R., de Souza, H.S.P., Prophylactic systemic P2X7 receptor blockade prevents experimental colitis. Biochim. Biophys. Acta 1842 (2014), 65–78.
124. Martin, B., Hirota, K., Cua, D.J., Stockinger, B., Veldhoen, M., Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31 (2009), 321–330.
125. Martinez-Augustin, O., Sanchez de Medina, F., Intestinal bile acid physiology and pathophysiology. World J. Gastroenterol. 14 (2008), 5630–5640.
126. Martinot, E., Sèdes, L., Baptissart, M., Lobaccaro, J.-M., Caira, F., Beaudoin, C., Volle, D.H., Bile acids and their receptors. Mol. Aspects Med., 2017, 10.1016/j.mam.2017.01.006 S0098-2997(16)30112-1.
127. Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., Tanaka, K., Identification of membrane-type receptor for bile acids (M-BAR). Biochem. Biophys. Res. Commun. 298 (2002), 714–719.
128. Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H.C., Rolph, M.S., Mackay, F., Artis, D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 (2009), 1282–1286.
129. Matsumoto, M., Kibe, R., Ooga, T., Aiba, Y., Kurihara, S., Sawaki, E., Koga, Y., Benno, Y., Impact of intestinal microbiota on intestinal luminal metabolome. Sci. Rep., 2, 2012, 233.
130. Mazmanian, S.K., Kasper, D.L., The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 6 (2006), 849–858.
131. Mazmanian, S.K., Liu, C.H., Tzianabos, A.O., Kasper, D.L., An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122 (2005), 107–118.
132. Mazmanian, S.K., Round, J.L., Kasper, D.L., A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008), 620–625.
133. Melo-Gonzalez, F., Hepworth, M.R., Functional and phenotypic heterogeneity of group 3 innate lymphoid cells. Immunology 150 (2017), 265–275.
134. Mencarelli, A., Renga, B., Migliorati, M., Cipriani, S., Distrutti, E., Santucci, L., Fiorucci, S., The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. J. Immunol. 183 (2009), 6657–6666.
135. Mente, A., Chalcraft, K., Ak, H., Davis, A.D., Lonn, E., Miller, R., Potter, M.A., Yusuf, S., Anand, S.S., McQueen, M.J., The relationship between trimethylamine-N-oxide and prevalent cardiovascular disease in a multiethnic population living in Canada. Can. J. Cardiol. 31 (2015), 1189–1194.
136. Metchnikoff, E., The Prolongation of Life: Optimistic Studies. 1908, G.P. Putnam's Sons.
137. Michael, A.J., Biosynthesis of polyamines and polyamine-containing molecules. Biochem. J. 473 (2016), 2315–2329.
138. Millard, A.L., Mertes, P.M., Ittelet, D., Villard, F., Jeannesson, P., Bernard, J., Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin. Exp. Immunol. 130 (2002), 245–255.
139. Miller-Fleming, L., Olin-Sandoval, V., Campbell, K., Ralser, M., Remaining mysteries of molecular biology: the role of polyamines in the cell. J. Mol. Biol. 427 (2015), 3389–3406.
140. Miyauchi, S., Gopal, E., Fei, Y.-J., Ganapathy, V., Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids. J. Biol. Chem. 279 (2004), 13293–13296.
141. Moore, K.J., Sheedy, F.J., Fisher, E.A., Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13 (2013), 709–721.
142. Morrison, D.J., Preston, T., Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7 (2016), 189–200.
143. Neves, A.R., Castelo-Branco, M.T.L., Figliuolo, V.R., Bernardazzi, C., Buongusto, F., Yoshimoto, A., Nanini, H.F., Coutinho, C.M.L.M., Carneiro, A.J.V., Coutinho-Silva, R., de Souza, H.S.P., Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease. Inflamm. Bowel Dis. 20 (2014), 444–457.
144. Nijmeijer, R.M., Gadaleta, R.M., van Mil, S.W.C., van Bodegraven, A.A., Crusius, J.B.A., Dijkstra, G., Hommes, D.W., de Jong, D.J., Stokkers, P.C.F., Verspaget, H.W., et al., Dutch Initiative on Crohn, Colitis (ICC). Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease. PLoS ONE, 6, 2011, e23745.
145. Nilsson, N.E., Kotarsky, K., Owman, C., Olde, B., Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun. 303 (2003), 1047–1052.
146. Nuttle, L.C., Dubyak, G.R., Differential activation of cation channels and non-selective pores by macrophage P2z purinergic receptors expressed in Xenopus oocytes. J. Biol. Chem. 269 (1994), 13988–13996.
147. O'Neill, L.A.J., Kishton, R.J., Rathmell, J., A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16 (2016), 553–565.
148. Ochoa-Repáraz, J., Mielcarz, D.W., Ditrio, L.E., Burroughs, A.R., Begum-Haque, S., Dasgupta, S., Kasper, D.L., Kasper, L.H., Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J. Immunol. 185 (2010), 4101–4108.
149. Panea, C., Farkas, A.M., Goto, Y., Abdollahi-Roodsaz, S., Lee, C., Koscsó B., Gowda, K., Hohl, T.M., Bogunovic, M., Ivanov, I.I., Intestinal monocyte-derived macrophages control commensal-specific Th17 responses. Cell Rep. 12 (2015), 1314–1324.
150. Pantosti, A., Tzianabos, A.O., Onderdonk, A.B., Kasper, D.L., Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect. Immun. 59 (1991), 2075–2082.
151. Park, J., Kim, M., Kang, S.G., Jannasch, A.H., Cooper, B., Patterson, J., Kim, C.H., Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 8 (2015), 80–93.
152. Parks, D.J., Blanchard, S.G., Bledsoe, R.K., Chandra, G., Consler, T.G., Kliewer, S.A., Stimmel, J.B., Willson, T.M., Zavacki, A.M., Moore, D.D., Lehmann, J.M., Bile acids: natural ligands for an orphan nuclear receptor. Science 284 (1999), 1365–1368.
153. Pascual, G., Fong, A.L., Ogawa, S., Gamliel, A., Li, A.C., Perissi, V., Rose, D.W., Willson, T.M., Rosenfeld, M.G., Glass, C.K., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437 (2005), 759–763.
154. Pérez-Cano, F.J., González-Castro, A., Castellote, C., Franch, A., Castell, M., Influence of breast milk polyamines on suckling rat immune system maturation. Dev. Comp. Immunol. 34 (2010), 210–218.
155. Perruzza, L., Gargari, G., Proietti, M., Fosso, B., D'Erchia, A.M., Faliti, C.E., Rezzonico-Jost, T., Scribano, D., Mauri, L., Colombo, D., et al. T follicular helper cells promote a beneficial gut ecosystem for host metabolic homeostasis by sensing microbiota-derived extracellular ATP. Cell Rep. 18 (2017), 2566–2575.
156. Pfeiffer, J.K., Virgin, H.W., Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine. Science, 351, 2016, aad5872.
157. Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23 (2017), 107–113.
158. Pluznick, J.L., Protzko, R.J., Gevorgyan, H., Peterlin, Z., Sipos, A., Han, J., Brunet, I., Wan, L.-X., Rey, F., Wang, T., et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc. Natl. Acad. Sci. USA 110 (2013), 4410–4415.
159. Pols, T.W.H., Nomura, M., Harach, T., Lo Sasso, G., Oosterveer, M.H., Thomas, C., Rizzo, G., Gioiello, A., Adorini, L., Pellicciari, R., et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab. 14 (2011), 747–757.
160. Proietti, M., Cornacchione, V., Rezzonico Jost, T., Romagnani, A., Faliti, C.E., Perruzza, L., Rigoni, R., Radaelli, E., Caprioli, F., Preziuso, S., et al. ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualism. Immunity 41 (2014), 789–801.
161. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., et al., MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
162. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
163. Qiu, J., Heller, J.J., Guo, X., Chen, Z.-M.E., Fish, K., Fu, Y.-X., Zhou, L., The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36 (2012), 92–104.
164. Qiu, Z., Cervantes, J.L., Cicek, B.B., Mukherjee, S., Venkatesh, M., Maher, L.A., Salazar, J.C., Mani, S., Khanna, K.M., Pregnane x receptor regulates pathogen-induced inflammation and host defense against an intracellular bacterial infection through Toll-like receptor 4. Sci. Rep., 6, 2016, 31936.
165. Ramirez-Carrozzi, V.R., Braas, D., Bhatt, D.M., Cheng, C.S., Hong, C., Doty, K.R., Black, J.C., Hoffmann, A., Carey, M., Smale, S.T., A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138 (2009), 114–128.
166. Rao, K., Safdar, N., Fecal microbiota transplantation for the treatment of Clostridium difficile infection. J. Hosp. Med. 11 (2016), 56–61.
167. Reichardt, N., Duncan, S.H., Young, P., Belenguer, A., McWilliam Leitch, C., Scott, K.P., Flint, H.J., Louis, P., Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 8 (2014), 1323–1335.
168. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
169. Ridlon, J.M., Kang, D.-J., Hylemon, P.B., Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47 (2006), 241–259.
170. Ríos-Covián, D., Ruas-Madiedo, P., Margolles, A., Gueimonde, M., de Los Reyes-Gavilán, C.G., Salazar, N., Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol., 7, 2016, 185.
171. Romano, K.A., Vivas, E.I., Amador-Noguez, D., Rey, F.E., Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio, 6, 2015, e02481.
172. Rooks, M.G., Garrett, W.S., Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16 (2016), 341–352.
173. Rothhammer, V., Mascanfroni, I.D., Bunse, L., Takenaka, M.C., Kenison, J.E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22 (2016), 586–597.
174. Round, J.L., Lee, S.M., Li, J., Tran, G., Jabri, B., Chatila, T.A., Mazmanian, S.K., The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332 (2011), 974–977.
175. Rutgeerts, P., Ghoos, Y., Vantrappen, G., Bile acid studies in patients with Crohn's colitis. Gut 20 (1979), 1072–1077.
176. Sayin, S.I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič M., Bäckhed, F., Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17 (2013), 225–235.
177. Segain, J.P., Raingeard de la Blétière, D., Bourreille, A., Leray, V., Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottière, H.M., Galmiche, J.P., Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47 (2000), 397–403.
178. Seldin, M.M., Meng, Y., Qi, H., Zhu, W., Wang, Z., Hazen, S.L., Lusis, A.J., Shih, D.M., Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB. J. Am. Heart Assoc., 5, 2016, e002767.
179. Seljeset, S., Siehler, S., Receptor-specific regulation of ERK1/2 activation by members of the “free fatty acid receptor” family. J. Recept. Signal Transduct. Res. 32 (2012), 196–201.
180. Sender, R., Fuchs, S., Milo, R., Revised estimates for the number of human and bacteria cells in the body. PLoS Biol., 14, 2016, e1002533.
181. Sender, R., Fuchs, S., Milo, R., Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164 (2016), 337–340.
182. Shah, Y.M., Ma, X., Morimura, K., Kim, I., Gonzalez, F.J., Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2007), G1114–G1122.
183. Shapiro, H., Suez, J., Elinav, E., Personalized microbiome-based approaches to metabolic syndrome management and prevention. J. Diabetes 9 (2017), 226–236.
184. Sharma, S., Erickson, K.M., Troutman, J.M., Complete tetrasaccharide repeat unit biosynthesis of the immunomodulatory bacteroides fragilis capsular polysaccharide A. ACS Chem. Biol. 12 (2017), 92–101.
185. Sharon, G., Garg, N., Debelius, J., Knight, R., Dorrestein, P.C., Mazmanian, S.K., Specialized metabolites from the microbiome in health and disease. Cell Metab. 20 (2014), 719–730.
186. Shi, L.Z., Faith, N.G., Nakayama, Y., Suresh, M., Steinberg, H., Czuprynski, C.J., The aryl hydrocarbon receptor is required for optimal resistance to Listeria monocytogenes infection in mice. J. Immunol. 179 (2007), 6952–6962.
187. Shi, Y., Lai, X., Ye, L., Chen, K., Cao, Z., Gong, W., Jin, L., Wang, C., Liu, M., Liao, Y., et al. Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization. Sci. Rep., 7, 2017, 42279.
188. Sina, C., Gavrilova, O., Förster, M., Till, A., Derer, S., Hildebrand, F., Raabe, B., Chalaris, A., Scheller, J., Rehmann, A., et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol. 183 (2009), 7514–7522.
189. Singh, N., Thangaraju, M., Prasad, P.D., Martin, P.M., Lambert, N.A., Boettger, T., Offermanns, S., Ganapathy, V., Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J. Biol. Chem. 285 (2010), 27601–27608.
190. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P.D., Manicassamy, S., Munn, D.H., et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40 (2014), 128–139.
191. Smart, M.L., Gu, B., Panchal, R.G., Wiley, J., Cromer, B., Williams, D.A., Petrou, S., P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J. Biol. Chem. 278 (2003), 8853–8860.
192. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., Glickman, J.N., Garrett, W.S., The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
193. Smythies, L.E., Sellers, M., Clements, R.H., Mosteller-Barnum, M., Meng, G., Benjamin, W.H., Orenstein, J.M., Smith, P.D., Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115 (2005), 66–75.
194. Sokol, H., Seksik, P., Furet, J.P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., Doré J., Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15 (2009), 1183–1189.
195. Sonnenburg, J.L., Bäckhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
196. Spor, A., Koren, O., Ley, R., Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9 (2011), 279–290.
197. Steliou, K., Boosalis, M.S., Perrine, S.P., Sangerman, J., Faller, D.V., Butyrate histone deacetylase inhibitors. Biores. Open Access 1 (2012), 192–198.
198. Stockinger, B., Di Meglio, P., Gialitakis, M., Duarte, J.H., The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 32 (2014), 403–432.
199. Sutterwala, F.S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G.S., Grant, E.P., Bertin, J., Coyle, A.J., Galán, J.E., Askenase, P.W., Flavell, R.A., Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24 (2006), 317–327.
200. Sutterwala, F.S., Haasken, S., Cassel, S.L., Mechanism of NLRP3 inflammasome activation. Ann. N Y Acad. Sci. 1319 (2014), 82–95.
201. Swann, J.R., Want, E.J., Geier, F.M., Spagou, K., Wilson, I.D., Sidaway, J.E., Nicholson, J.K., Holmes, E., Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl. Acad. Sci. USA 108:Suppl 1 (2011), 4523–4530.
202. Tan, T.G., Sefik, E., Geva-Zatorsky, N., Kua, L., Naskar, D., Teng, F., Pasman, L., Ortiz-Lopez, A., Jupp, R., Wu, H.-J.J., et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc. Natl. Acad. Sci. USA 113 (2016), E8141–E8150.
203. Tang, W.H.W., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., Wu, Y., Hazen, S.L., Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368 (2013), 1575–1584.
204. Tang, W.H.W., Wang, Z., Fan, Y., Levison, B., Hazen, J.E., Donahue, L.M., Wu, Y., Hazen, S.L., Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64 (2014), 1908–1914.
205. Tang, W.H.W., Wang, Z., Shrestha, K., Borowski, A.G., Wu, Y., Troughton, R.W., Klein, A.L., Hazen, S.L., Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J. Card. Fail. 21 (2015), 91–96.
206. Telesford, K.M., Yan, W., Ochoa-Reparaz, J., Pant, A., Kircher, C., Christy, M.A., Begum-Haque, S., Kasper, D.L., Kasper, L.H., A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 6 (2015), 234–242.
207. ter Steege, J.C., Forget, P.P., Buurman, W.A., Oral spermine administration inhibits nitric oxide-mediated intestinal damage and levels of systemic inflammatory mediators in a mouse endotoxin model. Shock 11 (1999), 115–119.
208. Terc, J., Hansen, A., Alston, L., Hirota, S.A., Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis. Eur. J. Pharm. Sci. 55 (2014), 12–19.
209. Thangaraju, M., Cresci, G., Itagaki, S., Mellinger, J., Browning, D.D., Berger, F.G., Prasad, P.D., Ganapathy, V., Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J. Gastrointest. Surg. 12 (2008), 1773–1781 discussion 1781–1782.
210. Thangaraju, M., Carswell, K.N., Prasad, P.D., Ganapathy, V., Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem. J. 417 (2009), 379–389.
211. Thangaraju, M., Cresci, G.A., Liu, K., Ananth, S., Gnanaprakasam, J.P., Browning, D.D., Mellinger, J.D., Smith, S.B., Digby, G.J., Lambert, N.A., et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69 (2009), 2826–2832.
212. Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., Schoonjans, K., Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 7 (2008), 678–693.
213. Tolhurst, G., Heffron, H., Lam, Y.S., Parker, H.E., Habib, A.M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., Gribble, F.M., Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61 (2012), 364–371.
214. Tremaroli, V., Karlsson, F., Werling, M., Ståhlman, M., Kovatcheva-Datchary, P., Olbers, T., Fändriks, L., le Roux, C.W., Nielsen, J., Bäckhed, F., Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 22 (2015), 228–238.
215. Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L.P., Harris, N.L., Marsland, B.J., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20 (2014), 159–166.
216. Trøseid, M., Ueland, T., Hov, J.R., Svardal, A., Gregersen, I., Dahl, C.P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J. Intern. Med. 277 (2015), 717–726.
217. Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., Offermanns, S., PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat. Med. 9 (2003), 352–355.
218. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
219. Turnbaugh, P.J., Bäckhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
220. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
221. Underhill, D.M., Gordon, S., Imhof, B.A., Núñez, G., Bousso, P., Élie Metchnikoff (1845–1916): celebrating 100 years of cellular immunology and beyond. Nat. Rev. Immunol. 16 (2016), 651–656.
222. Ussher, J.R., Lopaschuk, G.D., Arduini, A., Gut microbiota metabolism of L-carnitine and cardiovascular risk. Atherosclerosis 231 (2013), 456–461.
223. van der Beek, C.M., Bloemen, J.G., van den Broek, M.A., Lenaerts, K., Venema, K., Buurman, W.A., Dejong, C.H., Hepatic uptake of rectally administered butyrate prevents an increase in systemic butyrate concentrations in humans. J. Nutr. 145 (2015), 2019–2024.
224. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., Visser, C.E., Kuijper, E.J., Bartelsman, J.F.W.M., Tijssen, J.G.P., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368 (2013), 407–415.
225. Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., Fiorucci, S., The bile acid receptor FXR is a modulator of intestinal innate immunity. J. Immunol. 183 (2009), 6251–6261.
226. Veldhoen, M., Hirota, K., Westendorf, A.M., Buer, J., Dumoutier, L., Renauld, J.-C., Stockinger, B., The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453 (2008), 106–109.
227. Venkatesh, M., Mukherjee, S., Wang, H., Li, H., Sun, K., Benechet, A.P., Qiu, Z., Maher, L., Redinbo, M.R., Phillips, R.S., et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 41 (2014), 296–310.
228. Venkatraman, A., Ramakrishna, B.S., Shaji, R.V., Kumar, N.S.N., Pulimood, A., Patra, S., Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-kappaB. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003), G177–G184.
229. Vinolo, M.A.R., Ferguson, G.J., Kulkarni, S., Damoulakis, G., Anderson, K., Bohlooly-Y, M., Stephens, L., Hawkins, P.T., Curi, R., SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS ONE, 6, 2011, e21205.
230. Vinolo, M.A.R., Rodrigues, H.G., Hatanaka, E., Sato, F.T., Sampaio, S.C., Curi, R., Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22 (2011), 849–855.
231. Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R.S., Bartelsman, J.F.W.M., Dallinga-Thie, G.M., Ackermans, M.T., Serlie, M.J., Oozeer, R., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916.e7.
232. Wakade, C., Chong, R., Bradley, E., Thomas, B., Morgan, J., Upregulation of GPR109A in Parkinson's disease. PLoS One, 9, 2014, e109818.
233. Walker, A.W., Ince, J., Duncan, S.H., Webster, L.M., Holtrop, G., Ze, X., Brown, D., Stares, M.D., Scott, P., Bergerat, A., et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 5 (2011), 220–230.
234. Wang, H., Zhang, M., Soda, K., Sama, A., Tracey, K.J., Fetuin protects the fetus from TNF. Lancet 350 (1997), 861–862.
235. Wang, H., Chen, J., Hollister, K., Sowers, L.C., Forman, B.M., Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 3 (1999), 543–553.
236. Wang, Q., McLoughlin, R.M., Cobb, B.A., Charrel-Dennis, M., Zaleski, K.J., Golenbock, D., Tzianabos, A.O., Kasper, D.L., A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J. Exp. Med. 203 (2006), 2853–2863.
237. Wang, B., Morinobu, A., Horiuchi, M., Liu, J., Kumagai, S., Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. Cell. Immunol. 253 (2008), 54–58.
238. Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B.M., Huang, W., Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 48 (2008), 1632–1643.
239. Wang, Y.-D., Chen, W.-D., Yu, D., Forman, B.M., Huang, W., The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice. Hepatology 54 (2011), 1421–1432.
240. Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt, E.B., Fu, X., Chung, Y.-M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
241. Wang, Y., Begum-Haque, S., Telesford, K.M., Ochoa-Repáraz, J., Christy, M., Kasper, E.J., Kasper, D.L., Robson, S.C., Kasper, L.H., A commensal bacterial product elicits and modulates migratory capacity of CD39(+) CD4 T regulatory subsets in the suppression of neuroinflammation. Gut Microbes 5 (2014), 552–561.
242. Wang, Z., Tang, W.H.W., Buffa, J.A., Fu, X., Britt, E.B., Koeth, R.A., Levison, B.S., Fan, Y., Wu, Y., Hazen, S.L., Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur. Heart J. 35 (2014), 904–910.
243. Wen, A.Y., Sakamoto, K.M., Miller, L.S., The role of the transcription factor CREB in immune function. J. Immunol. 185 (2010), 6413–6419.
244. Wikoff, W.R., Anfora, A.T., Liu, J., Schultz, P.G., Lesley, S.A., Peters, E.C., Siuzdak, G., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. USA 106 (2009), 3698–3703.
245. Willemsen, L.E.M., Koetsier, M.A., van Deventer, S.J.H., van Tol, E.A.F., Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 52 (2003), 1442–1447.
246. Wise, A., Foord, S.M., Fraser, N.J., Barnes, A.A., Elshourbagy, N., Eilert, M., Ignar, D.M., Murdock, P.R., Steplewski, K., Green, A., et al. Molecular identification of high and low affinity receptors for nicotinic acid. J. Biol. Chem. 278 (2003), 9869–9874.
247. Wrzosek, L., Miquel, S., Noordine, M.-L., Bouet, S., Joncquel Chevalier-Curt, M., Robert, V., Philippe, C., Bridonneau, C., Cherbuy, C., Robbe-Masselot, C., et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol., 11, 2013, 61.
248. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S.A., Bewtra, M., Knights, D., Walters, W.A., Knight, R., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
249. Yang, F., Huang, X., Yi, T., Yen, Y., Moore, D.D., Huang, W., Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res. 67 (2007), 863–867.
250. Yaron, J.R., Gangaraju, S., Rao, M.Y., Kong, X., Zhang, L., Su, F., Tian, Y., Glenn, H.L., Meldrum, D.R., K(+) regulates Ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells. Cell Death Dis., 6, 2015, e1954.
251. Yissachar, N., Zhou, Y., Ung, L., Lai, N.Y., Mohan, J.F., Ehrlicher, A., Weitz, D.A., Kasper, D.L., Chiu, I.M., Mathis, D., Benoist, C., An intestinal organ culture system uncovers a role for the nervous system in microbe-immune crosstalk. Cell 168 (2017), 1135–1148.e12.
252. Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D'Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.
253. Zhang, M., Caragine, T., Wang, H., Cohen, P.S., Botchkina, G., Soda, K., Bianchi, M., Ulrich, P., Cerami, A., Sherry, B., Tracey, K.J., Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J. Exp. Med. 185 (1997), 1759–1768.
254. Zhang, M., Borovikova, L.V., Wang, H., Metz, C., Tracey, K.J., Spermine inhibition of monocyte activation and inflammation. Mol. Med. 5 (1999), 595–605.
255. Zhang, F., Luo, W., Shi, Y., Fan, Z., Ji, G., Should we standardize the 1,700-year-old fecal microbiota transplantation?. Am. J. Gastroenterol., 107, 2012, 1755 author reply, 1755–1756.
256. Zhu, S., Ashok, M., Li, J., Li, W., Yang, H., Wang, P., Tracey, K.J., Sama, A.E., Wang, H., Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol. Med. 15 (2009), 275–282.
257. Zhu, W., Gregory, J.C., Org, E., Buffa, J.A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165 (2016), 111–124.